Cirrhosis |
Cirrhosis (Primary Biliary); Cirrhosis of the Liver; Liver Cirrhosis |
Clinical Trial: Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer.
This study is currently recruiting patients.
Verified by Rennes University Hospital September 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Liver Cancer Hepatocellular Carcinoma Cirrhosis Liver Fibrosis | Drug: Oral Impact® | Phase II Phase III |
MedlinePlus related topics: Cirrhosis; Liver Cancer
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Prospective, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Effect of Oral Immune-Enhancing Nutritional Supplement on Hepatic Function After Liver Resection for Primary or Secondary Cancer on Cirrhosis or Liver Fibrosis
Secondary Outcomes: 1) Liver regeneration kinetics:; - bile production at days 1, 3, 5 and 7; - factor V, γ-glutathione transferase, α-foetoprotein at days 1, 3, 5, 7, 10 and 30; - liver volume at days 10 and 30; 2) Immunological biomarkers; 3) Infections
Expected Total Enrollment: 50
Study start: April 2003
Eligibility
Inclusion Criteria:
- Adult over 18 years
- Hepatectomy of at least 2 segments
- For primary or secondary cancer
- With cirrhosis (Child Pugh <8) or liver fibrosis (fibrosis score of 3)
- Informed written consent
Exclusion Criteria:
Location and Contact Information
Eric Bellissant, MD, PhD 33-2-9928-9200 eric.bellissant@chu-rennes.fr
France
Service de Réanimation Chirurgicale - Hôpital Pontchaillou, Rennes, 35033, France; Recruiting
Philippe Seguin, MD, Principal Investigator
Karim Boudjema, MD, PhD, Principal Investigator
Yves Gandon, MD, Sub-Investigator
Gilbert Semana, MD, Sub-Investigator
Yannick Mallédant, MD, Study Director, Rennes University Hospital
Eric Bellissant, MD, PhD, Study Chair, Rennes University Hospital
Philippe Seguin, MD, Principal Investigator, Rennes University Hospital
Karim Boudjema, MD, PhD, Principal Investigator, Rennes University Hospital
More Information
Publications
Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp SH, van Deventer SJ, Ince C, Eysman L, Kesecioglu J. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet. 2001 Sep 1;358(9283):696-701.
Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, Eickhoff U, Kemen M. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999 Dec;134(12):1309-16.
Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg. 1999 Apr;134(4):428-33.
Last Updated: September 8, 2005
Record first received: September 8, 2005
ClinicalTrials.gov Identifier: NCT00151671
Health Authority: France: Afssaps - French Health Products Safety Agency
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Alcohol Alert #42. Alcohol and the Liver (National Institute on Alcohol Abuse and Alcoholism)
- Alcoholic Hepatitis (Mayo Foundation for Medical Education and Research)

Not Signed In -

